Michael Mertzman
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Biochemical and Molecular Research
Most-Cited Works
- → Practical olefin hydroamination with nitroarenes(2015)524 cited
- → Identification of N-Methyl Nicotinamide and N-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)(2019)87 cited
- → Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity(2011)48 cited
- → Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase(2012)42 cited
- → Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection(2013)36 cited
- → Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage(2019)35 cited
- → Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease(2011)26 cited
- → Improved synthesis of quinaldines by the skraup reaction(1993)22 cited
- → Optimization of Pharmacokinetics through Manipulation of Physicochemical Properties in a Series of HCV Inhibitors(2011)18 cited
- → The solution conformation Ac‐Pen‐Arg‐Gly‐Asp‐Cys‐OH, a potent fibrinogen receptor antagonist(1993)17 cited